Centanafadine
ADHD
Phase 3Active
Key Facts
About Otsuka Holdings
Otsuka Holdings Co., Ltd. is a multinational pharmaceutical and healthcare company founded in 1964, headquartered in Tokyo, Japan. The company has built a strong reputation in central nervous system disorders, with major commercial successes including the antipsychotic Abilify and depression treatment Rexulti. Otsuka operates globally with a focus on innovation in psychiatry, neurology, oncology, and nephrology, maintaining a robust pipeline of novel therapeutics and a commitment to addressing unmet medical needs.
View full company profileTherapeutic Areas
Other ADHD Drugs
| Drug | Company | Phase |
|---|---|---|
| Vyvanse (lisdexamfetamine) | Takeda Pharmaceutical | Commercial |
| TCM-based formulation | Regencell Bioscience | Preclinical |
| Methylphenidate ER | Lupin Limited | Approved |
| Adderall XR® | Supernus Pharmaceuticals | Approved/Commercial |
| Intuniv® | Supernus Pharmaceuticals | Approved/Commercial |
| Mydayis® | Supernus Pharmaceuticals | Approved/Commercial |